银屑病
保健品
医学
依那西普
代谢综合征
血脂谱
内科学
国家胆固醇教育计划
胆固醇
皮肤病科
肿瘤坏死因子α
肥胖
病理
作者
Nevena Skroza,Ilaria Proietti,Nunzia Bernardini,Giorgio La Viola,Francesca Nicolucci,Riccardo Pampena,Ersilia Tolino,Sara Zuber,Mario Mancini,V Soccodato,V Balduzzi,Concetta Potenza
出处
期刊:PubMed
日期:2013-12-01
卷期号:148 (6): 661-5
被引量:8
摘要
Psoriasis is a systemic inflammatory immune-mediated skin disease. Recently a relationship with metabolic syndrome in terms of psoriasis severity and response to therapy was observed.We performed an open-label randomized controlled study to evaluate the role of a nutraceutical containing Q10 coenzyme, Krill-oil, lipoic acid, resveratrol, Vitis vinifera seed oil, vitamin E and selenium in addition to etanercept therapy for patients affected by psoriasis and metabolic syndrome. Forty patients were enrolled and divided into two arms, one receiving only etanercept, one other receiving also the neutraceutical. After a period of 3 months (T1) a second evaluation of the considered parameters was performed.At T1 statistically significant differences were detected in HDL cholesterol and triglycerides values both comparing the two arms and in the nutraceutical arm.Our results show that the dietary addiction of the nutraceutical to the etanercept therapy in patients affected by both psoriasis and metabolic syndrome could help to restore the normal lipid profile.
科研通智能强力驱动
Strongly Powered by AbleSci AI